What You Should Know:
Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced that it is launching Valtruis, a unique portfolio company that will invest in and partner with value-based care driven healthcare companies. WCAS is committing an initial $300M to this platform.
Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an expansive network that advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience.
Valtruis Team
Valtruis’ founding leadership team includes Managing Partners Anna Haghgooie, Tracy Bahl and Karey Witty, who collectively have been influential in growing numerous disruptive and market-leading healthcare businesses as both operators and investors throughout their respective careers.
– Anna Haghgooie was most recently Managing Director of the Blue Venture Fund and Sandbox Industries, where she worked with numerous notable healthcare services and technology companies, including four from start-up.
– Tracy Bahl previously served as President and CEO of OneOncology, a network of leading community oncology practices across the U.S. Prior to OneOncology, Mr. Bahl served as EVP of Health Plans for CVS Health; Executive Chairman of Emdeon and CEO of Uniprise, a UnitedHealth Group Company.
– Karey Witty served most recently as COO of Envision Healthcare, a provider of physician and advanced practice services to healthcare facilities in the U.S. He also previously served as CEO of Corizon Health, EVP and CFO of naviHealth (a former WCAS portfolio company), CFO of HealthSpring and CFO of Centene Corp.
“We are very excited to announce the formation of Valtruis and are thrilled to work with Anna, Tracy and Karey to partner with transformative companies across the U.S. healthcare ecosystem. We believe Valtruis is well positioned to leverage WCAS’s longstanding relationships and history of building market-leading healthcare businesses alongside tremendous operating talent and expertise to deliver a differentiated resource to emerging companies looking to accelerate the adoption of value-based care,” said David Caluori, General Partner at WCAS.
